References
- Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA303(20), 2035–2042 (2010).
- Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA294(10), 1255–1259 (2005).
- Tsai CL, Sobrino JA, Camargo CA Jr. National study of emergency department visits for acute exacerbation of chronic obstructive pulmonary disease. Acad. Emerg. Med.15, 1275–1283 (2008).
- Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med.176(6), 532–555 (2007).
- Walker AM. Confounding by indication. Epidemiology7(4), 335–336 (1996).
- Tsai CL, Camargo CA Jr. Methodological considerations, such as directed acyclic graphs, for studying ‘acute on chronic’ disease epidemiology: chronic obstructive pulmonary disease example. J. Clin. Epidemiol.62(9), 982–990 (2009).
- Walker AM. Observation and Inference: An Introduction to the Methods of Epidemiology. Epidemiology Resources Inc., Chestnut Hill, MA, USA (1991).
- Klungel OH, Martens EP, Psaty BM et al. Methods to assess intended effects of drug treatment in observational studies are reviewed. J. Clin. Epidemiol.57(12), 1223–1231 (2004).
- Glynn RJ, Schneeweiss S, Sturmer T. Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin. Pharmacol. Toxicol.98(3), 253–259 (2006).
- Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J. Clin. Epidemiol.58(4), 323–337 (2005).
- Hernan MA, Robins JM. Instruments for causal inference: an epidemiologist’s dream? Epidemiology17(4), 360–372 (2006).
- Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables. Annu. Rev. Public Health19, 17–34 (1998).
- Martens EP, Pestman WR, de Boer A, Belitser SV, Klungel OH. Instrumental variables: application and limitations. Epidemiology17(3), 260–267 (2006).
- McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA272(11), 859–866 (1994).
- Harris KM, Remler DK. Who is the marginal patient? Understanding instrumental variables estimates of treatment effects. Health Serv. Res.33(5 Pt 1), 1337–1360 (1998).
- Ginde AA, Tsai CL, Blanc P, Camargo CA Jr. Positive predictive value of ICD-9-CM codes to detect acute exacerbation of chronic obstructive pulmonary disease in the emergency department. Jt Comm. J. Qual. Patient Saf.34, 678–680 (2008).
- Conway PH, Clancy C. Comparative-effectiveness research – implications of the Federal Coordinating Council’s report. N. Engl. J. Med.361(4), 328–330 (2009).
- Dreyer NA, Schneeweiss S, McNeil BJ et al. GRACE principles: recognizing high-quality observational studies of comparative effectiveness. Am. J. Manag. Care16(6), 467–471 (2010).
- Johnson ML, Crown W, Martin BC, Dormuth CR, Siebert U. Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report – Part III. Value Health12(8), 1062–1073 (2009).
- Iglehart JK. Prioritizing comparative-effectiveness research – IOM recommendations. N. Engl. J. Med.361(4), 325–328 (2009).
- Krishnan JA, Mularski RA. Acting on comparative effectiveness research in COPD. JAMA303(23), 2409–2410 (2010).